Theranos, once Silicon Valley's sexiest startup, recently announced plans to shut down its blood-test facilities and lay off almost half its workers.
But that shouldn't mean the premise of Theranos is flawed. In fact, CEO Elizabeth Holmes' vision — to remove the friction in blood diagnostics — is bang on the money. For all involved, blood draws are a pain — quite literally. The opportunity for a more convenient, accurate, and less painful draw, especially for chronic conditions such as diabetes, is tremendous.
Read Full Article »